Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis have?
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis has 853 citations in the OpenAlex counts ScholarIQ stores.
When was Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis published?
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis has 2010 year in the ScholarIQ index.
What is the open-access status of Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis?
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis has closed oa status in the ScholarIQ index.
What is the DOI of Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis?
The DOI for Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis is on the source record.
What is the PMID of Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis?
The PMID for Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis is on the source record.
What is the OpenAlex record for Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis?
The OpenAlex for Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis is on the source record.